Literature DB >> 9625833

A clinicopathologic study of the resected cases of adenosquamous carcinoma of the lung.

M Kamiyoshihara1, T Hirai, O Kawashima, S Ishikawa, Y Morishita, A Maeshima.   

Abstract

Ten cases of surgically resected adenosquamous carcinoma of the lung were studied clinicopathologically, and their outcome was compared with that of adenocarcinomas and squamous cell carcinomas of the lung. The frequency rate of adenosquamous carcinoma was 1.5% of 668 primary lung cancers resected in our hospital. The survival curves of patients with adenosquamous carcinomas, adenocarcinomas, and squamous cell carcinomas indicated that the outcome of adenosquamous carcinoma was statistically poorer than that of adenocarcinoma (p=0. 01), and tended to be poorer than that of squamous cell carcinoma (p=0.051). The amount of adenocarcinoma component did not affect the survival rate. Five-year survival was not obtained in this series. Although our series is small, this study suggests that adenosquamous carcinoma of the lung is an aggressive tumor with poor prognosis.

Entities:  

Mesh:

Year:  1998        PMID: 9625833     DOI: 10.3892/or.5.4.861

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

1.  Clinicopathological characteristics and prognosis of patients with adenosquamous lung carcinoma.

Authors:  Ye Guo; Lin Jia; Guo-Guang Shao; Hong-Wei Sun; Xing-Xing Wang; Guan-Jun Wang; Ke-Wei Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

2.  Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung.

Authors:  H Kanazawa; M Ebina; N Ino-Oka; M Shimizukawa; T Takahashi; S Fujimura; T Imai; T Nukiwa
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

3.  Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: risk of coexistent double cancer.

Authors:  Hidetaka Uramoto; Sohsuke Yamada; Takeshi Hanagiri
Journal:  J Cardiothorac Surg       Date:  2010-10-29       Impact factor: 1.637

4.  Treatment for Patients With Early Stage Adenosquamous Lung Cancer.

Authors:  Jiaxi He; Shuben Li; Hui Pan; Jianxing He
Journal:  JTO Clin Res Rep       Date:  2020-03-04

5.  Prognostic factors of T2aN0M0 (T3-4cmN0M0, stage IB) non-small-cell lung cancer after surgery: Single-center real-world research.

Authors:  Lei Liu; Jiaqi Zhang; Guige Wang; Ke Zhao; Chao Guo; Yeye Chen; Cheng Huang; Shanqing Li
Journal:  Thorac Cancer       Date:  2021-11-03       Impact factor: 3.500

6.  Clinical Outcomes of Different Generations of EGFR Tyrosine Kinase Inhibitors in Advanced Lung Adenosquamous Carcinoma.

Authors:  Minjuan Hu; Bo Zhang; Jianlin Xu; Shuyuan Wang; Yiming Zhao; Lele Zhang; Baohui Han
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.